Cart
sales@molnova.com
NVP-BSK805 2HCl
CAS No. ——
NVP-BSK805 2HCl ( —— )
Catalog No. M17712 CAS No. ——
NVP-BSK805 2HCl(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 176 | Get Quote |
|
| 10MG | 241 | Get Quote |
|
| 25MG | 446 | Get Quote |
|
| 50MG | 630 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNVP-BSK805 2HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionNVP-BSK805 2HCl(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2.
-
DescriptionNVP-BSK805 2HCl(IC50=0.5 nM), a specific and effective ATP-competitive JAK2 inhibitor, is more than 20-fold specificity over JAK1, JAK3 and TYK2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorJAK1| JAK2| JAK3| Tyk2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight563.47
-
Molecular FormulaC27H28F2N6O·2HCl
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CNCCC1n1cc(cn1)c1nc2c(cccc2nc1)c1cc(c(c(c1)F)CN1CCOCC1)F.Cl.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Baffert F, et al. Mol Cancer Ther, 2010, 9(7), 1945-1955.
molnova catalog
related products
-
4-(1H-Pyrazol-4-yl)-...
Detail unknown.
-
Resminostat hydrochl...
A potent inhibitor of HDAC1/3/6 with IC50s of 43-72 nM; induces hyperacetylation of histone H4 and apoptosis in MM cell lines (IC50=2.5-3 uM).
-
SIS17
SIS17 is a potent and selective HDAC 11 inhibitor with an IC50 value of 0.83 μM. SIS17 is active in cells and inhibited the demyristoylation of a known HDAC11 substrate serine hydroxymethyl transferase 2 without inhibiting other HDACs.
